ClinVar Miner

Submissions for variant NM_000251.3(MSH2):c.2100del (p.Glu701fs)

dbSNP: rs1553369113
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Department of Pathology and Laboratory Medicine, Sinai Health System RCV000503012 SCV000592535 pathogenic Lynch syndrome no assertion criteria provided clinical testing The MSH2 p.Glu701LysfsX9 deletion variant was not identified in the literature, nor was it identified in dbSNP, HGMD, UMD, “Mismatch Repair Genes Variant Database”, “InSiGHT Colon Cancer Database”, “MMR Gene Unclassified Variants Database”, or the COSMIC database. The p.Glu701LysfsX9 deletion variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at codon 701 and leads to a premature stop codon 9 codons downstream. This alteration is then predicted to result in a truncated or absent protein and loss of function. Loss of function variants of the MSH2 gene are an established mechanism of disease in Lynch syndrome and this is the type of variant expected to cause the disorder. In summary, based on the above information, this variant meets our laboratory’s criteria to be classified as pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.